The Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 Prevents Lethal Synergism between a Paramyxovirus and Streptococcus pneumoniae

Documenti analoghi

• Efficacy of the Novel Parainfluenza Virus Hemagglutinin-Neuraminidase Inhibitor BCX 2798 in Mice—Further Evaluation
  di: Alymova, Irina V., et al.
  Pubblicazione: (2009)
• Efficacy of Novel Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 against Human Parainfluenza Viruses In Vitro and In Vivo
  di: Alymova, Irina V., et al.
  Pubblicazione: (2004)
• Effect of Hemagglutinin-Neuraminidase Inhibitors BCX 2798 and BCX 2855 on Growth and Pathogenicity of Sendai/Human Parainfluenza Type 3 Chimera Virus in Mice
  di: Watanabe, Makiko, et al.
  Pubblicazione: (2009)
• Receptor-binding specificity of the human parainfluenza virus type 1 hemagglutinin–neuraminidase glycoprotein
  di: Alymova, Irina V, et al.
  Pubblicazione: (2012)
• Loss of the N-Linked Glycan at Residue 173 of Human Parainfluenza Virus Type 1 Hemagglutinin-Neuraminidase Exposes a Second Receptor-Binding Site
  di: Alymova, Irina V., et al.
  Pubblicazione: (2008)